Back

A real-world study assessing the dosage pattern and demographics of patients with HFrEF initiated on ARNi in India: the ADD ARNI study

29 August 2026 (11:15 - 12:00)
Organised by: Logo
Congress Presentation Part of: Heat failure complexity across ventricular assist devices, inflammation, stroke, and education Pharmacotherapy ESC2026 Premium Access ESC Congress 2026 European Society of Cardiology

About the speaker

Photo
Doctor Pathiyil Balagopalan Jayagopal

LAKSHMI HOSPITAL, Palakkad (India)

5 More presentations in this session

Presentation thumbnail
Inflammation links liver fibrosis development to diastolic myocardial function in early alcohol-associated liver disease
Doctor W. Grander (Hall in Tyrol, AT)
Abstract Slides Video
Presentation thumbnail
Association between bacteremia and stroke events in patients with HeartMate 3
Doctor K. Muto (JP)
Abstract Slides Video
Presentation thumbnail
Shifts in MCS utilization and early outcomes within a bridge-to-decision strategy for cardiogenic shock across the destination therapy Era
Doctor H. Tomita (Osaka, JP) Doctor T. Watanabe (Saitama, JP)
Abstract Slides Video
Presentation thumbnail
The impact of beta-blocker treatment on all-cause mortality and rehospitalization in general population with heart failure with preserved ejection fraction and comorbidity-specific subgroups
Mr R. Szczerba (Katowice, PL)
Abstract Slides Video
Presentation thumbnail
Feasibility of pacing with digital twins of brainstem circuits to restore heart rate variability in heart failure
Doctor K. Hamzaraj (Vienna, AT)
Abstract Slides Video

Access the full session

Session thumbnail
Heat failure complexity across ventricular assist devices, inflammation, stroke, and education

The Event

Event poster

ESC Congress 2026

29 August 2026 11:15 CET
You may be interested in
thumbnail
Congress Presentation
Real-world comparison between ARNI and RAS Blockade in Patients with HFrEF
22 May 2023
thumbnail
Congress Presentation
Treatment gradients across the left ventricular ejection fraction spectrum in ambulatory and acute heart failure: a multinational registry analysis
29 August 2026
thumbnail
Congress Presentation
Angiotensin receptor-neprilysin inhibitor (Sacubitril/Valsartan) in cancer therapy-related cardiac dysfunction: real-world experience from a nurse-led cardio-oncology clinic
31 August 2024
thumbnail
Congress Presentation
Treatment with sacubitril/valsartan and improvement of ventricular-arterial coupling in heart failure with reduced ejection fraction
25 August 2023

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources